JACQUELINE HAYES: Open Payments
NPI 1134275662 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$328 in 18 payments from 10 companies in 2025. Trend: 2023 $1,964 · 2024 $1,638 · 2025 $328
Food & beverage: $328
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $63 |
| Novartis Pharmaceuticals Corporation | 3 | $56 |
| ABBVIE INC. | 2 | $45 |
| Lilly USA, LLC | 2 | $41 |
| PFIZER INC. | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Amgen Inc. | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: UBRELVY, MOUNJARO, ENTRESTO, Ozempic, Wegovy, TRINTELLIX, Auvelity, LEQVIO.
Industry payments across MO — which companies pay providers there.
